Di-Ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cells

International Journal of Environmental Research and Public Health

Volumn 11, Issue 5, 2014, Pages 5006-5019

  Sims, Jennifer Nicole ^a   Graham, Barbara ^a   Pacurari, Maricica ^a   Leggett, Sophia S ^b   Tchounwou, Paul B ^a   Ndebele, Kenneth ^a  

^a Jackson State University   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

Author keywords

DEHP; Glioblastoma; RNA interference; S100P

Indexed keywords

PEPTIDES AND PROTEINS; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PROTEIN S100P; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; POLLUTANT; S100P PROTEIN, HUMAN; TUMOR PROTEIN;

BIOMARKER; BRAIN; CANCER; CELL ORGANELLE; CHEMOTHERAPY; MOLECULAR ANALYSIS; NERVOUS SYSTEM DISORDER; RNA; SURVIVAL;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; GENE SILENCING; GLIOBLASTOMA CELL LINE; POLLUTANT; PROTEIN FUNCTION; BRAIN TUMOR; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; GLIOBLASTOMA; HUMAN; LENTIVIRINAE; METABOLISM; TOXICITY; TUMOR CELL LINE;

APOPTOSIS; BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DIETHYLHEXYL PHTHALATE; ENVIRONMENTAL POLLUTANTS; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GLIOBLASTOMA; HUMANS; LENTIVIRUS; NEOPLASM PROTEINS;

EID: 84900497893     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110505006     Document Type: Article

References (25)

1. Polivka, J., Jr.; Polivka, J.; Rohan, V.; Topolcan, O.; Ferda, J. New molecularly targeted therapies for glioblastoma multiforme. Anticancer Res. 2012, 32, 2935-2946.
2. Amberger-Murphy, V. Hypoxia helps glioma to fight therapy. Curr. Cancer Drug Targets 2009, 9, 381-390.
3. Burton, E.C.; Lamborn, K.R.; Forsyth, P.; Scott, J.; O'Campo, J.; Uyehara-Lock, J. Prados, M.; Berger, M.; Passe, S.; Uhm, J.; et al. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin. Cancer Res. 2002, 8, 180-187.
4. Omuro, A.; DeAngelis, L.M. Glioblastoma and other malignant gliomas: A clinical review. JAMA 2013, 310, 1842-1850.
5. Clapp, R.W.; Jacobs, M.M.; Loechler, E.L. Environmental and occupational causes of cancer: New evidence 2005-2007. Rev. Environ. Health 2008, 23, 1-37.
6. Lyche, J.L.; Gutleb, A.C.; Bergman, A.; Eriksen, G.S.; Murk, A.J.; Ropstad, E.; Saunders, M.; Skaare, J.U. Reproductive and developmental toxicity of phthalates. J. Toxicol. Environ. Health Pt. B 2009, 12, 225-249.
7. Casals-Casas, C.; Feige, J.N.; Desvergne, B. Interference of pollutants with PPARs: Endocrine disruption meets metabolism. Int J. Obesity 2008, 32, S53-S61.
8. Li, L.; Zhang, T.; Qin, X.S.; Ge, W.; Ma, H.G.; Sun, L.L.; Hou, Z.M.; Chen, H.; Chen, P.; Qin, G.Q.; et al. Exposure to diethylhexyl phthalate (DEHP) results in a heritable modification of imprint genes DNA methylation in mouse oocytes. Mol. Biol Rep. 2014, 41, 1227-1235.
9. Becker, T.; Gerke, V.; Kube, E.; Weber, K. S100P, a novel Ca(2+)-binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties. Eur. J. Biochem. 1992, 207, 541-547.
10. Schafer, B.W.; Wicki, R.; Engelkamp, D.; Mattei, M.G.; Heizmann, C.W. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: Rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995, 25, 638-643.
11. Norremolle, A.; Budtz-Jorgensen, E.; Fenger, K.; Nielsen, J.E.; Sorensen, S.A.; Hasholt, L. 4p16.3 haplotype modifying age at onset of Huntington disease. Clin. Genet. 2009, 75, 244-250.
12. Ingersoll, R.G.; Hetmanski, J.; Park, J.W.; Fallin, M.D.; McIntosh, I.; Wu-Chou, Y.H.; Chen, P.K.; Yeow, V.; Chong, S.S.; Cheah, F.; et al. Association between genes on chromosome 4p16 and non-syndromic oral clefts in four populations. Eur. J. Hum. Genet. 2010, 18, 726-732.
13. Zollino, M.; Murdolo, M.; Neri, G. The terminal 760 kb region on 4p16 is unlikely to be the critical interval for growth delay in Wolf-Hirschhorn syndrome. J. Med. Genet. 2008, 45, doi:10.1136/jmg.2008.058370.
14. Zenteno, J.C.; Ruiz, G.; Perez-Cano, H.J.; Camargo, M. Familial Wolfram syndrome due to compound heterozygosity for two novel WFS1 mutations. Mol. Vis. 2008, 14, 1353-1357.
15. Raelson, J.V.; Little, R.D.; Ruether, A.; Fournier, H.; Paquin, B.; van Eerdewegh, P.; Bradley, W.E.; Croteau, P.; Nguyen-Huu, Q.; Segal, J.; et al. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc. Natl. Acad. Sci. USA 2007, 104, 14747-14752.
16. Singh, R.K.; Indra, D.; Mitra, S.; Mondal, R.K.; Basu, P.S.; Roy, A.; Roychowdhury, S.; Panda, C.K. Deletions in chromosome 4 differentially associated with the development of cervical cancer: Evidence of slit2 as a candidate tumor suppressor gene. Hum. Genet. 2007, 122, 71-81.
17. Yuan, R.H.; Chang, K.T.; Chen, Y.L.; Hsu, H.C.; Lee, P.H.; Lai, P.L.; Jeng, Y.M. S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors. PLoS One 2013, 8, doi:10.1371/journal.pone.0065501.
18. Da Silva, I.D.G.; Hu, Y.F.; Russo, I.H.; Ao, X.; Salicioni, A.M.; Yang, X.; Russo, J. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int. J. Oncol. 2000, 16, 231-240.
19. Kita, H.; Hikichi, Y.; Hikami, K.; Tsuneyama, K.; Cui, Z.G.; Osawa, H.; Ohnishi, H.; Mutoh, H.; Hoshino, H.; Bowlus, C.L.; et al. Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J. Gastroenterol. 2006, 41, 1053-1063.
20. Fuentes, M.K.; Nigavekar, S.S.; Arumugam, T.; Logsdon, C.D.; Schmidt, A.M.; Park, J.C.; Huang, E.H. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis. Colon Rectum 2007, 50, 1230-1240.
21. Jiang, H.; Hu, H.; Tong, X.; Jiang, Q.; Zhu, H.; Zhang, S. Calcium-binding protein S100P and cancer: Mechanisms and clinical relevance. J. Cancer Res. Clin. Oncol. 2012, 138, 1-9.
22. Johnston, J.C.; Gasmi, M.; Lim, L.E.; Elder, J.H.; Yee, J.K.; Jolly, D.J.; Campbell, K.P.; Davidson, B.L.; Sauter, S.L. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 1999, 73, 4991-5000.
23. Arumugam, T.; Simeone, D.M.; van Golen, K.; Logsdon, C.D. S100P promotes pancreatic cancer growth, survival, and invasion. Clin. Cancer Res. 2005, 11, 5356-5364.
24. Basu, G.D.; Azorsa, D.O.; Kiefer, J.A.; Rojas, A.M.; Tuzmen, S.; Barrett, M.T.; Trent, J.M.; Kallioniemi, O.; Mousses, S. Functional evidence implicating S100P in prostate cancer progression. Int. J. Cancer 2008, 123, 330-339.
25. Van Meir, E.G.; Kikuchi, T.; Tada, M.; Li, H.; Diserens, A.C.; Wojcik, B. E; Cavenee, W.K. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 1994, 54, 649-652.